“I cannot overstate the impact of this device on my management of kidney stone patients," says J. Stuart Wolf, Jr., MD, FACS.
J. Stuart Wolf, Jr., MD, FACS
Recently, J. Stuart Wolf, Jr., MD, FACS, of Dell Medical School in Texas presented an international webinar for the Endourological Society about the Steerable Ureteroscopic Renal Evacuation with CVAC Aspiration System from Calyxo, Inc. This is the second generation of the device, which received FDA clearance in February 2024.1
In the video, Wolf demonstrates his first 3 cases with the device, and there was a lively discussion following the presentation with questions from the 2 moderators and the online participants.
Click to watch the video here.
The revolutionary CVAC device is a single-use aspiration ureteroscope that integrates ureteroscopy, dedicated irrigation, and a 7 Fr vacuum channel, allowing aspiration of fragments up to 2.3 mm. The laser fiber is positioned in the vacuum channel using a flexible laser bridge that is also used to clear dust and/or fragments from the tip. There are multiple dedicated irrigation nozzles around the perimeter of the tip, such that a vortex of fluid is created that very effectively and passively aspirates stone dust as laser lithotripsy progresses. This keeps the operative field clear and allows the surgeon to efficiently perform lithotripsy without the stone dust interfering with vision. Once lithotripsy is completed, the surgeon removes the laser bridge and then takes advantage of the full 7 Fr channel and a regulated increase of irrigation to actively aspirate larger fragments using surgeon-controlled suction. This is a low-pressure system owing to the large outflow channel. The device facilitates the efficient achievement of an immediate stone free status.
As the presentation neared completion, Wolf remarked, “I cannot overstate the impact of this device on my management of kidney stone patients.”
Reference:
1. Calyxo announces FDA Clearance for new, redesigned CVAC System. News release. Calyxo. March 26, 2024. Accessed April 22, 2024. https://calyxoinc.com/news/calyxo-fda-approved-cvac-system-kidney-stones/
Bundled payment program covers kidney stone care
July 22nd 2024"One day, we're going to have to move away from fee for service, so we'd be wise to try to navigate those waters ahead of time, so we're not left dealing with the aftermath when someone else has implemented it for us," says Ruchika Talwar, MD.
FDA grants 510(k) clearance to Ambu’s single-use ureteroscope
July 2nd 2024"This clearance in the US of our new ureteroscopy solution not only demonstrates a market expansion for Ambu; it is a testament to the progressive shift towards single-use solutions within the field of urology," says Britt Meelby Jensen.
Data support shock wave lithotripsy for pediatric patients with kidney stones
May 28th 2024Regarding patient-reported outcomes, those who underwent URS showed higher urinary symptoms, greater pain intensity, and greater pain interference at 1 week following surgery compared with those who underwent SWL.